MJ Biopharm Pvt Ltd - Company Review
MJ Biopharm Pvt Ltd - Company ReviewSummary
MJ Biopharm Pvt Ltd (MJ Biopharm), a subsidiary of MJ Group, is a manufacturer and distributor of pharmaceutical products and formulations. The company develops products in various therapeutic areas such as diabetology, cardiology, NSAID, anti-inflammatory and anti-biotics, among others. Its portfolio of products includes Amlodipine, Atorvastatin, Candesartan, Enalapril Maleate, Warfarin, Vinpocetine, Drotaverin and Omeprazole, among others. MJ Biopharm develops animal and human rDNA Insulin and also products in other dosage forms such as tablets, capsules, cephalosporin injectables, other injectable ampoules and vials. The company works in collaboration with other organizations such as Diosynth B.V, Bioton and Sanofi Aventis for the development and commercialization of various products. MJ Biopharm is headquartered in Mumbai, Maharashtra, India.
This comprehensive company report of MJ Biopharm Pvt Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.